Home » Stocks » RSPI

RespireRx Pharmaceuticals, Inc. (RSPI)

Stock Price: $0.0346 USD -0.0040 (-10.83%)
Updated Jan 15, 2021 9:30 AM EST - Market closed
Market Cap 187,238
Revenue (ttm) n/a
Net Income (ttm) -3.87M
Shares Out 22.44M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $0.0346
Previous Close $0.0388
Change ($) -0.0040
Change (%) -10.83%
Day's Open 0.0345
Day's Range 0.0302 - 0.0425
Day's Volume 2,384,324
52-Week Range 0.02 - 1.499

News

There are no news available yet.

About RSPI

RespireRx Pharmaceuticals engages in the discovery and development of pharmaceuticals for the treatment of respiratory disorders. It has two drug platforms comprising ampakines, which are small molecule compounds to enhance the excitatory actions of the neurotransmitter glutamate at the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor complex; and cannabinoids, primarily dronabinol, a synthetic derivative for use in refractory chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS. The co... [Read more...]

Industry
Biotechnology
Founded
1987
Stock Exchange
OTCMKTS
Ticker Symbol
RSPI
Full Company Profile

Financial Performance

Financial Statements